REPLIGEN CORP (RGEN) FY2026 Q2 P&L / Income Statement

REPLIGEN CORP (RGEN) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue

204,128,000 US dollars

Cost of goods sold

94,091,000 US dollars

Gross profit (calculated)

110,037,000 US dollars

Operating expenses (calculated)

96,061,000 US dollars

Income from operations

13,976,000 US dollars

Other income (expense), net

177,000 US dollars

Income before income taxes

14,153,000 US dollars

Income tax provision

9,145,000 US dollars

Net income

5,008,000 US dollars

Asia Pacific ("APAC") & Rest of World (calculated)

34,701,760 US dollars

Europe (calculated)

65,320,960 US dollars

North America (calculated)

104,105,280 US dollars

Research and development

14,417,000 US dollars

Selling, general and administrative

76,618,000 US dollars

Restructuring activities and other charges

2,718,000 US dollars

Change in fair value of contingent consideration

2,308,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.